Lifecore Biomedical, Inc. De (LFCR) Operating Leases (2019 - 2025)

Lifecore Biomedical has reported Operating Leases for 7 years, with the latest figure at $5.4 million in Q1 2025.

• On a quarterly basis, Operating Leases rose 6.17% year-over-year to $5.4 million in Q1 2025; TTM through Feb 2025 was $5.4 million, a 6.17% increase from a year earlier, with the FY2024 full-year figure at $1.7 million, down 82.19% from the prior year.
• Operating Leases was $5.4 million for Q1 2025 at Lifecore Biomedical, down from $7.4 million in the prior quarter.
• The five-year high for Operating Leases was $17.9 million in Q1 2021, with the low at $1.7 million in Q2 2024.
• Average Operating Leases over 5 years is $8.9 million, with a median of $7.8 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Operating Leases surged 32.96% in 2023, then slumped 82.19% in 2024.
• Over 5 years, Operating Leases stood at $11.3 million in 2021, then sank by 38.12% to $7.0 million in 2022, then surged by 32.96% to $9.3 million in 2023, then slipped by 20.47% to $7.4 million in 2024, then dropped by 27.23% to $5.4 million in 2025.
• The last three Operating Leases figures came in at $5.4 million (Q1 2025), $7.4 million (Q4 2024), and $4.8 million (Q3 2024), per Business Quant data.